Astrazeneca Vaccine For Covid
- All
- News
- Videos
-
AstraZeneca Drops Covid Vaccine Weeks After Rare Side Effect Report
AstraZeneca has initiated a global withdrawal of its COVID-19 vaccine, days after it was reported that the British pharmaceutical company admitted that the jab can cause rare side effects.
-
AstraZeneca Admits Covishield Jab Has Rare Side-Effect. Should You Worry?
Thrombosis Thrombocytopenia Syndrome (TTS) -- a blood clot disorder -- is a rare side effect of AstraZeneca's Covid vaccine, and the risks far outweigh the benefits of the jab, doctors said today.
-
High Hopes For Nasal Covid Vaccines Despite "Disappointing" Trial
Nasal vaccines could still be a powerful future weapon in the fight against Covid-19 despite "disappointing" recent trial results for an AstraZeneca spray, experts say.
-
AstraZeneca Nasal Spray Vaccine For Covid Fizzles In Small, Early Trial
AstraZeneca Plc's ambitions for developing an easier formulation of its Covid-19 vaccine -- one that might help curb contagion as well -- suffered a setback Monday as the nasal spray failed in an early test.
-
AstraZeneca Claims Positive Medicine Trial For "Severe" Covid
A treatment for people at risk of death from coronavirus has revealed good results in a late-stage trial, its maker AstraZeneca announced Wednesday.
-
European Union Drugs Regulator Approves AstraZeneca Jab As Covid Booster
AstraZeneca's Covid jab has won approval for use as a booster or third jab in the European Union, the British drugs giant confirmed Monday.
-
Taiwan Okays Locally Made Covid Vaccine For Emergency Use
Taiwan's government on Monday said it had granted emergency-use approval to a coronavirus vaccine made locally by Medigen, with experts saying early data suggested it was similarly effective to AstraZeneca's jabs.
-
Thailand Says AstraZeneca Asked To Delay Delivery Of 61 Million Vaccine Doses
AstraZeneca has asked Thailand to extend the timeline for the delivery of 61 million doses of its COVID-19 vaccine by five months, a deputy minister said on Thursday, a move likely to disrupt further the country's sluggish vaccine rollout.
-
Australia Restricts AstraZeneca Vaccine For All Under 60 Due to Clotting Concerns
Australia recommended that AstraZeneca's Covid-19 jab should not be given to people under 60 on Thursday, a fresh blow to the country's glacial vaccine rollout.
-
What Top European Agency Official Said On AstraZeneca Use Amid Concerns
A top official in the European Medicines Agency said it might be worth abandoning AstraZeneca's coronavirus vaccine for all age groups where alternatives are available, in an interview published Sunday.
-
AstraZeneca Drops Covid Vaccine Weeks After Rare Side Effect Report
AstraZeneca has initiated a global withdrawal of its COVID-19 vaccine, days after it was reported that the British pharmaceutical company admitted that the jab can cause rare side effects.
-
AstraZeneca Admits Covishield Jab Has Rare Side-Effect. Should You Worry?
Thrombosis Thrombocytopenia Syndrome (TTS) -- a blood clot disorder -- is a rare side effect of AstraZeneca's Covid vaccine, and the risks far outweigh the benefits of the jab, doctors said today.
-
High Hopes For Nasal Covid Vaccines Despite "Disappointing" Trial
Nasal vaccines could still be a powerful future weapon in the fight against Covid-19 despite "disappointing" recent trial results for an AstraZeneca spray, experts say.
-
AstraZeneca Nasal Spray Vaccine For Covid Fizzles In Small, Early Trial
AstraZeneca Plc's ambitions for developing an easier formulation of its Covid-19 vaccine -- one that might help curb contagion as well -- suffered a setback Monday as the nasal spray failed in an early test.
-
AstraZeneca Claims Positive Medicine Trial For "Severe" Covid
A treatment for people at risk of death from coronavirus has revealed good results in a late-stage trial, its maker AstraZeneca announced Wednesday.
-
European Union Drugs Regulator Approves AstraZeneca Jab As Covid Booster
AstraZeneca's Covid jab has won approval for use as a booster or third jab in the European Union, the British drugs giant confirmed Monday.
-
Taiwan Okays Locally Made Covid Vaccine For Emergency Use
Taiwan's government on Monday said it had granted emergency-use approval to a coronavirus vaccine made locally by Medigen, with experts saying early data suggested it was similarly effective to AstraZeneca's jabs.
-
Thailand Says AstraZeneca Asked To Delay Delivery Of 61 Million Vaccine Doses
AstraZeneca has asked Thailand to extend the timeline for the delivery of 61 million doses of its COVID-19 vaccine by five months, a deputy minister said on Thursday, a move likely to disrupt further the country's sluggish vaccine rollout.
-
Australia Restricts AstraZeneca Vaccine For All Under 60 Due to Clotting Concerns
Australia recommended that AstraZeneca's Covid-19 jab should not be given to people under 60 on Thursday, a fresh blow to the country's glacial vaccine rollout.
-
What Top European Agency Official Said On AstraZeneca Use Amid Concerns
A top official in the European Medicines Agency said it might be worth abandoning AstraZeneca's coronavirus vaccine for all age groups where alternatives are available, in an interview published Sunday.
